Table 2.

Duration of hypoglycemia according to age, duration of diabetes, estimated glomerular filtration rate, body mass index, sulfonylurea dose or diabetic complications

	Duration (min/h)	Duration (min/h)	P
Hypoglycemia of <54 mg/dL
Age (years)	<75	≥75
	0.45 (n = 178)	0.81 (n = 91)	0.11
Duration of diabetes (years)	<15	≥15
	0.29 (n = 111)	0.80 (n = 151)	<0.05
eGFR (mL/min/1.73 m2)	<60	≥60
	0.64 (n = 94)	0.55 (n = 171)	0.68
BMI (kg/m2)	<25	≥25
	0.65 (n = 68)	0.45 (n = 199)	0.38
Gliclazide (mg/day)	≤20	>20
	0.23 (n = 58)	0.84 (n = 27)	<0.05
Glimepiride (mg/day)	≤1	>1
	0.42 (n = 130)	1.5 (n = 38)	<0.01
	(+)	(−)
Diabetic retinopathy	0.78 (n = 88)	0.48 (n = 173)	0.18
Diabetic nephropathy	0.50 (n = 103)	0.61 (n = 66)	0.58
Diabetic neuropathy	0.81 (n = 102)	0.42 (n = 167)	0.07
Macrovascular complications	0.57 (n = 69)	0.54 (n = 200)	0.89
Hypoglycemia of <70 mg/dL
Age (years)	<75	≥75
	2.2 (n = 178)	3.0 (n = 91)	0.09
Duration of diabetes (years)	<15	≥15
	1.7 (n = 111)	3.0 (n = 151)	<0.01
eGFR (mL/min/1.73 m2)	<60	≥60
	3.1 (n = 94)	2.1 (n = 171)	0.06
BMI (kg/m2)	<25	≥25
	2.6 (n = 68)	2.2 (n = 199)	0.32
Gliclazide (mg/day)	≤20	>20
	1.6 (n = 58)	4.2 (n = 27)	<0.01
Glimepiride (mg/day)	≤1	>1
	1.8 (n = 130)	4.2 (n = 38)	<0.01
	(+)	(−)
Diabetic retinopathy	2.9 (n = 88)	2.3 (n = 173)	0.26
Diabetic nephropathy	2.8 (n = 103)	2.2 (n = 166)	0.26
Diabetic neuropathy	2.9 (n = 102)	2.2 (n = 167)	0.12
Macrovascular complications	2.5 (n = 69)	2.4 (n = 200)	0.74

Data are adjusted by glycated hemoglobin level. P < 0.05 was considered significant. BMI, body mass index; eGFR, estimated glomerular filtration rate.

[Correction added on 2 October, after first online publication: Some alignments in the table have been amended.]